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The accuracy of diagnostic tests *in patients with presumed uveal melanomas is uncertain. In tumours that require enucleation, the diagnostic accuracy reported by most ocular oncology units has been over 98%. -5 34 We have managed several ciliochoroidal neoplasms that had characteristics of a uveal melanoma, on the basis of non-invasive tests, but were shown to be non-melanoma simulating lesions on cytopathological examination. Histopathological evaluation after ciliochoroidectomy confirmed these diagnoses. '8 In this study we report a consecutive series of 100 patients with a presumed diagnosis of a uveal melanoma (on the basis of clinical, ultrasonographic, and fluorescein angiographic studies); a minority of these patients would have been incorrectly treated if only noninvasive diagnostic tests had been used to establish a presumptive diagnosis.
Materials and methods
We retrospectively reviewed the data from 100 consecutive patients, who had a presumptive diagnosis of uveal melanoma on the basis of non-invasive tests, and then had fine needle aspiration biopsies (FNABs) before planned insertion of an 125I brachytherapy source, tantalum marker rings for charged particle treatment, or a cyclochoroidectomy. All patients were managed before July 1992 and the last follow up was obtained in September 1994.
Patients were managed in the ocular oncology unit and had given written and oral consent before all studies. All patients were initially examined with multiple observer clinical, fluorescein angiographic, and ultrasonographic techniques. On the basis of those studies a presumptive diagnosis of a uveal melanoma was made and patients were scheduled for non-enucleation treatment. 1 All patients had intraoperative tumour localisation before both fine needle aspiration biopsy and treatment. A limbal peritomy was fashioned, the four recti muscles were isolated and controlled with 2-0 sutures. Tumours were localised with both indirect corneal transillumination as well as by direct localisation with a point light source and indirect ophthalmoscopy. All fine needle aspiration biopsies were performed with a 25 gauge needle; most were done through a transscleral route, and some through a transvitreal approach. In all cases the site of needle entry was isolated and, as the needle was withdrawn, the site was sealed with glue.
As previously described, the specimens were all analysed initially in the operating room 3-5 mm thick, and the risk of more than one aspirate was felt not to be justified. In the other three cases, inadequate biopsies were obtained even though the lesions were over 4-5 mm in thickness. All cytological diagnoses were concordant with histology in the seven tumours managed with cyclochoroidectomy; three of these were benign tumours with a history of documented growth and four were melanomas.
Two patients with a known history of a systemic malignancy were biopsied. Non-invasive diagnostic test results were inconclusive; both had medium sized, amelanotic uveal tumours of uncertain aetiology; the cytopathological data confirmed the diagnoses of uveal melanomas. In nine other cases the fine needle aspiration biopsy data established a diagnosis different from melanoma.
Four patients had clinical findings of a uveal melanoma, but had a melanocytoma on cytopathological examination of fine needle aspiration biopsy material. Figure 1 shows a clinical photograph of such a very atypical tumour. Similarly, on ultrasound (Fig 2) the pattern was most consistent with a uveal melanoma. On serial evaluation over 3 years this lesion remains stable and visual acuity is unchanged at 20/20.
Two patients had uveal mass lesions with some characteristics of primary uveal melanomas, but some clinical or ultrasound features that were not entirely diagnostic. Both had evidence of metastatic disease on cytological evaluation. One patient had typical clinical and ultrasonographic features of a uveal melanoma (Fig 3) , but on fine needle aspiration biopsy had a lesion most consistent with an isolated primary carcinoid (Fig 4) . Strains for S-100 and HMB-45 were negative, and the 2 year follow up showed no evidence of other systemic neoplasms before his death from a myocardial infarct. One patient had a presumably benign RPE tumour that had grown and was successfully resected; others had melanocytomas or metastases.
Discussion
The accuracy of uveal melanoma diagnosis in many clinical settings is uncertain. While several investigators, including our group, have shown over 99%/o accuracy in the diagnosis of large tumours that required enucleation, the specificity of non-invasive diagnostic tests in smaller tumours is less certain. 1-5 8 In one enucleated series, overly optimistic accuracy rates were reported, since the diagnostically difficult cases with opaque media, were excluded from analysis.5
Pigmented choroidal tumours less than 3 mm in thickness and less than 10 mm in diameter often can not be differentiated on the basis of clinical, fluorescein, and angiographic or ultrasonographic studies.6 7 Fortunately, most of these cases can be followed serially and do not require therapy unless growth is documented.7 In medium size tumours the accuracy of diagnosis is less clear cut. A number of reports in the literature document a myriad of simulating lesions that mimic a melanoma pattern on clinical, ultrasonographic, and fluorescein angiographic studies.9-'9 Some reports of surgical resection of presumed uveal melanomas document the higher rate of false diagnosis in smaller tumours or those in anterior locations. 20 In this study of presumed uveal melanomas large enough to be scheduled for alternative therapy, at least 9% did not have uveal melanoma diagnosed on cytopathological evaluation of the tumour.
The implications of this study are threefold. Firstly, FNAB results had a significant impact on management. Some patients who require therapy for tumours that are not large enough to require enucleation are not correctly diagnosed on the basis of non-invasive tests. In some of these cases radiation therapy is not required. Radiation morbidity can be avoided in such patients with correct diagnosis. In others, an ineffective radiation dose would have been delivered with subsequent treatment failure if the results of only non-invasive tests would have been used to plan treatment. Two patients, with presumed metastatic lesions that were shown to be primary melanomas, would have received inadequate radiation. We have seen this misdiagnosis occur previously, with subsequent referral to us when the presumed metastasis continues to grow after receiving approximately 40 Gy of photon irradiation. In two other patients with non-invasive test data most consistent with a melanoma, metastatic choroidal tumours were diagnosed with FNAB. These later two patients were therefore treated with a lower dose of radiation (40 Gy) and presumably lower complications than had they received a higher dose needed for a melanoma. Secondly, in studies of uveal melanoma mortality after radiation it is likely that a minority of patients thought to have melanoma may not, in fact, have intraocular neoplasms associated with tumour related mortality. It is thus possible that the survival reported after some series of irradiated uveal melanomas may be slightly better because of inclusion of these atypical, simulating lesions. Thirdly, this study and a number of others continue to document the very low observed morbidity associated with uveal melanoma fine needle aspiration biopsy.24-32 While some investigators have noted small numbers of tumour cells in the needle track, there are no reports of spread of uveal melanoma as a result of fine needle aspiration biopsy.33 34 No significant complications were noted from needle biopsy in this study; however, several important caveats need to be emphasised. (1) While in this trial we performed FNABs on all patients who required alternative invasive therapy; this is not our routine clinical practice, and patients outside of this study who have classic findings on non-invasive tests do not have needle biopsies. Similarly, patients with very large tumours scheduled for enucleation did not routinely have fine needle aspiration biopsies. (2) The accuracy of FNAB is almost entirely dependent on the skill and techniques used in cytopathology. In our experience, where needle biopsies are immediately analysed in the operating room, the incidence of false negative biopsies is <5%; some centres with delayed processing at an adjacent institution have noted as high as a 25% inadequate specimen rate. 35 Cytological evaluation in the operating room allows a second biopsy attempt if the first specimen is inadequate. This approach lowers, but does not eliminate, false negative results. (3) Accuracy of cell type classification is almost wholly dependent on the skill of the cytopathologist, but should be as high as 95% with the techniques we have used. (4) It is uncertain with multivariate analysis how prognostically important cytological cell type classification is when compared with clinical measures of survival such as patient age, largest tumour size, and tumour location. (5) While at last follow up, the clinical response of patients who were treated without surgical resection is concordant with their cytopathological diagnosis, longer follow up may demonstrate some change. In resected uveal melanocytomas the cytopathology and histology were congruent. It is possible that a false negative result could occur using these techniques; however, we have not observed that to date. In none of the patients with benign cytological diagnosis has growth occurred; however, longer follow up, such as in the case presented in Figure 1 , might show growth. Certainly there have been rare reports of melanocytomas undergoing malignant regeneration, and sampling 'error' could occur in such a case where a malignant degenerative focus of tumour could be not sampled and therefore considered a benign lesion.
